About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Ctnnb1
catenin beta 1
MGI:88276
254 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ 		anemia J:142150
decreased hematocrit J:142150
extramedullary hematopoiesis J:142150
increased granulosa cell tumor incidence J:149060
increased metastatic potential J:142150, J:149060
increased ovary tumor incidence J:142150
increased testis tumor incidence J:149060
premature death J:142150
pulmonary embolism J:142150
seminiferous tubule degeneration J:149060
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 		increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
ApcMin/ApcMin
Ctnnb1tm4.1Wbm/Ctnnb1+
involves: 129 * 129P2/OlaHsd * C57BL/6 		embryonic lethality between implantation and somite formation, complete penetrance J:156864
ApcMin/Apctm1Tno
Ctnnb1tm4.1Wbm/Ctnnb1+
involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6 		normal craniofacial phenotype J:156864
increased hepatocellular carcinoma incidence J:156864
intestine polyps J:156864
normal nervous system phenotype J:156864
Apctm1Rak/Apc+
Ctnnb1tm1.2Wvv/Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6J 		abnormal telencephalon development J:185942
embryonic lethality, complete penetrance J:185942
rostral body truncation J:185942
Apctm1Rsmi/Apc+
Ctnnb1tm1Wvv/Ctnnb1+
Tg(Fabp1-cre)1Jig/?
involves: 129P2/OlaHsd * C57BL/6J * FVB/N 		increased gastrointestinal tumor incidence J:185942
Apctm1Tno/Apctm1Tno
Ctnnb1tm4.1Wbm/Ctnnb1+
involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6 		decreased tumor incidence J:156864
Apctm2Rfo/Apc+
Ctnnb1tm1.2Wvv/Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6J 		embryonic lethality, complete penetrance J:185942
rostral body truncation J:185942
Axin1tm4Cos/Axin1tm4Cos
Ctnnb1tm2.1Kem/Ctnnb1+
involves: 129S1/Sv * 129X1/SvJ * FVB/N 		abnormal brain morphology J:147293
abnormal facial morphology J:147293
abnormal head morphology J:147293
abnormal nose morphology J:147293
cleft palate J:147293
normal mortality/aging J:147293
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Ctnnb1tm1Mmt/Ctnnb1+
Krt14tm1.1(cre)Wbm/Krt14+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ 		decreased tumor-free survival time J:199091
increased hair follicle number J:199091
increased salivary gland tumor incidence J:199091
increased squamous cell carcinoma incidence J:199091
Cdkn1atm1Led/Cdkn1atm1Led
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Upk2-cre)6Xrw/0
involves: 129S6/SvEvTac * 129X1/SvJ * FVB/N 		increased urinary bladder carcinoma incidence J:234236
premature death J:234236
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Ptentm1Rps/Ptentm1Rps
Tg(Tyr-cre/ERT2)13Bos/0
involves: 129/Sv * C57BL/6J * FVB * SJL 		increased melanoma incidence J:155731
Col1a1tm2(tetO-CTNNB1*)Hoch/Col1a1tm2(tetO-CTNNB1*)Hoch
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
involves: 129S4/SvJae * C57BL/6 		abnormal crypts of Lieberkuhn morphology J:191050
abnormal intestinal epithelium morphology J:191050
abnormal intestinal goblet cell morphology J:191050
abnormal large intestine crypts of Lieberkuhn morphology J:191050
abnormal small intestine crypts of Lieberkuhn morphology J:191050
Ctnnb1Bfc/Ctnnb1+
Dkk1tm1Lmgd/Dkk1+
either: (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl) or (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl * C57BL/6) 		abnormal eye morphology J:170646
abnormal head morphology J:170646
preweaning lethality, incomplete penetrance J:170646
Ctnnb1Bfc/Ctnnb1+
Dkk1tm1Lmgd/Dkk1+
Lrp6Gw/Lrp6+
either: (involves: 101/H * 129 * BALB/cCrl * C3H) or (involves: 101/H * 129 * BALB/cCrl * C3H * C57BL/6) 		abnormal head size J:170646
caudal body truncation J:170646
Ctnnb1Bfc/Ctnnb1+
Lrp6Gw/Lrp6+
either: (involves: 101/H * BALB/cCrl * C3H) or (involves: 101/H * BALB/cCrl * C3H * C57BL/6) 		abnormal head size J:170646
Ctnnb1Bfc/Ctnnb1Bfc
Dkk1tm1Lmgd/Dkk1+
either: (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl) or (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl * C57BL/6) 		abnormal head size J:170646
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6 		abnormal cervical lymph node morphology J:71744
abnormal coat appearance J:71744
abnormal coat/ hair morphology J:71744
abnormal cornea epithelium morphology J:71744
abnormal cornea stroma morphology J:71744
abnormal eye morphology J:71744
abnormal eyelid margin morphology J:71744
abnormal foot pad morphology J:71744
abnormal hair follicle development J:71744
abnormal hair growth J:71744
abnormal intestinal goblet cell morphology J:71744
abnormal macrophage physiology J:71744
abnormal nitric oxide homeostasis J:71744
abnormal peripheral lymph node morphology J:71744
abnormal small intestine morphology J:71744
abnormal sweat gland morphology J:71744
abnormal vibrissa follicle morphology J:71744
absent hair follicles J:71744
absent Meibomian glands J:71744
absent peripheral lymph nodes J:71744
absent Peyer's patches J:71744
absent popliteal lymph nodes J:71744
alopecia J:71744
blindness J:71744
conjunctivitis J:71744
deafness J:71744
decreased body size J:71744
decreased hair follicle number J:71744
decreased litter size J:71744
decreased Peyer's patch number J:71744
domed cranium J:71744
dry eyes J:71744
early eyelid opening J:71744
gastrointestinal hemorrhage J:71744
growth retardation of incisors J:71744
growth retardation of molars J:71744
Harderian gland atrophy J:71744
hunched posture J:71744
impaired balance J:71744
increased granulocyte number J:71744
increased hair follicle apoptosis J:71744
increased hepatocyte apoptosis J:71744
increased inflammatory response J:71744
increased leukocyte cell number J:71744
increased susceptibility to otitis media J:71744
increased susceptibility to parasitic infection J:71744
keratoconjunctivitis sicca J:71744
kinked tail J:71744
lethargy J:71744
liver hemorrhage J:71744
misaligned incisors J:71744
narrow eye opening J:71744
premature death J:71744
prenatal lethality, incomplete penetrance J:71744
short incisors J:71744
small axillary lymph nodes J:71744
small brachial lymph nodes J:71744
small molars J:71744
small Peyer's patches J:71744
sparse vibrissae J:71744
tremors J:71744
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1tm1(Nfkbia)Rsu
involves: 129P2/OlaHsd * C57BL/6 		prenatal lethality, complete penetrance J:71744
Ctnnb1tm1.2Wvv/Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6J 		increased gastrointestinal tumor incidence J:185942
increased intestinal adenocarcinoma incidence J:185942
increased intestinal adenoma incidence J:185942
Ctnnb1tm1.2Wvv/Ctnnb1tm1.2Wvv
involves: 129P2/OlaHsd * C57BL/6J 		abnormal anterior head development J:185942
abnormal craniofacial development J:185942
abnormal cranium morphology J:185942
abnormal head morphology J:185942
abnormal mandibular prominence morphology J:185942
abnormal maxillary prominence morphology J:185942
abnormal nasal capsule morphology J:185942
abnormal tongue morphology J:185942
absent maxilla J:185942
facial cleft J:185942
microcephaly J:185942
perinatal lethality, complete penetrance J:185942
Ctnnb1tm1Max/Ctnnb1+
Hesx1tm1Icar/Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ 		abnormal forebrain development J:181005
anophthalmia J:181005
microphthalmia J:181005
small embryonic telencephalon J:181005
Ctnnb1tm1Max/Ctnnb1+
Hesx1tm1(cre)Jpmb/Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ 		abnormal forebrain development J:181005
anophthalmia J:181005
microphthalmia J:181005
small embryonic telencephalon J:181005
Ctnnb1tm1Max/Ctnnb1tm2Kem
Hesx1tm1(cre)Jpmb/Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ 		anophthalmia J:181005
microphthalmia J:181005
small embryonic telencephalon J:181005
Ctnnb1tm1Mmt/Ctnnb1+
Tcf7tm1Cle/Tcf7+
involves: 129P2/OlaHsd * 129X1/SvJ 		abnormal bone structure J:98430
Ctnnb1tm1Mmt/Ctnnb1+
Trp53tm1Brn/Trp53+
Tg(Fabp7-cre,-lacZ)3Gtm/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA 		increased medulloblastoma incidence J:186709
Ctnnb1tm1Mmt/Ctnnb1+
Fgfr3tm4Cxd/Fgfr3+
Tg(Upk2-cre)6Xrw/0
involves: 129S6/SvEvTac * 129X1/SvJ * FVB/N 		abnormal urinary bladder urothelium morphology J:174242
increased lung tumor incidence J:174242
normal neoplasm J:174242
premature death J:174242
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
Tg(CYP19A1-cre)1Jri/0
involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 		decreased circulating estradiol level J:186144
decreased circulating progesterone level J:186144
decreased granulosa cell apoptosis J:186144
decreased tumor-free survival time J:186144
impaired granulosa cell differentiation J:186144
increased circulating follicle stimulating hormone level J:186144
increased circulating luteinizing hormone level J:186144
increased granulosa cell proliferation J:186144
increased granulosa cell tumor incidence J:186144
increased ovary tumor incidence J:186144
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N 		increased urinary bladder carcinoma incidence J:164579
premature death J:164579
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Wap-cre)11738Mam/0
Tg(Wap-Hgf)402Mig/0
FVB.Cg-Ctnnb1tm1Mmt Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig 		abnormal mammary gland growth during lactation J:206839
abnormal mammary gland morphology J:206839
increased mammary gland tumor incidence in breeding females J:206839
increased mammary gland tumor incidence in virgin females J:206839
mammary gland alveolar hyperplasia J:206839
Ctnnb1tm1Mmt/Ctnnb1+
Krastm4Tyj/Kras+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 		increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
seminiferous tubule degeneration J:186144
Ctnnb1tm1Mmt/Ctnnb1+
Krastm4Tyj/Kras+
Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N 		increased lung tumor incidence J:174242
Ctnnb1tm1Mmt/Ctnnb1+
Krastm4Tyj/Kras+
Tg(CYP19A1-cre)1Jri/0
involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 		decreased circulating estradiol level J:186144
decreased circulating progesterone level J:186144
impaired granulosa cell differentiation J:186144
increased circulating follicle stimulating hormone level J:186144
increased circulating luteinizing hormone level J:186144
increased granulosa cell tumor incidence J:186144
increased ovary tumor incidence J:186144
premature death J:186144
Ctnnb1tm1Mmt/Ctnnb1+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Prom1tm1(cre/ERT2)Gilb/Prom1+
involves: 129S6/SvEvTac * 129X1/SvJ 		increased intestinal adenocarcinoma incidence J:144215
premature death J:144215
Ctnnb1tm1Mmt/Ctnnb1+
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Wap-cre)11738Mam/0
Tg(Wap-Hgf)402Mig/0
FVB.Cg-Cxcr4tm2Yzo Ctnnb1tm1Mmt Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig 		decreased mammary gland tumor incidence in breeding females J:206839
Ctnnb1tm1Mmt/Ctnnb1+
Wnt9btm1.1Amc/Wnt9btm1.2Amc
Tg(Cdh16-cre)91Igr/0
involves: 129X1/SvJ * ICR 		kidney cyst J:151498
Ctnnb1tm1Mmt/Ctnnb1+
Krastm1Bbd/Kras+
Tg(Pbsn-cre)4Prb/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 		increased prostate gland tumor incidence J:143034
premature death J:143034
squamous metaplasia of bulbourethral gland J:143034
squamous metaplasia of urethral gland J:143034
Ctnnb1tm1Mmt/Ctnnb1+
Rspo1tm1Mcch/Rspo1tm1Mcch
Tg(Nr5a1-cre)5Asc/?
involves: 129/Sv * C57BL/6 * CBA 		embryonic lethality, incomplete penetrance J:133933
normal reproductive system phenotype J:133933
Ctnnb1tm1Mmt/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 		abnormal osteoclast differentiation J:178340
abnormal trabecular bone morphology J:178340
absent bone marrow cell J:178340
decreased bone marrow cell number J:178340
decreased bone resorption J:178340
decreased osteoclast cell number J:178340
extramedullary hematopoiesis J:178340
increased bone trabecula number J:178340
increased bone volume J:178340
increased compact bone volume J:178340
increased splenocyte number J:178340
increased trabecular bone thickness J:178340
increased trabecular bone volume J:178340
osteopetrosis J:178340
normal skeleton phenotype J:178340
Ctnnb1tm1Mmt/Ctnnb1+
Pik3catm1Gilb/Pik3ca+
Trp53tm1Brn/Trp53+
Tg(Fabp7-cre,-lacZ)3Gtm/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA 		increased medulloblastoma incidence J:186709
Ctnnb1tm1Mmt/Ctnnb1+
Igs2tm1(CAG-Met)Zsu/Igs2+
Tg(Pbsn-cre)4Prb/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N 		increased prostate gland adenocarcinoma incidence J:284956
increased prostate intraepithelial neoplasia incidence J:284956
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Gt(ROSA)26Sortm2(Sp8)Lma/Gt(ROSA)26Sor+
Tg(Msx2-cre)5Rem/0
involves: 129X1/SvJ * C57BL/6 * CBA 		normal limbs/digits/tail phenotype J:223057
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Krastm4Tyj/Kras+
Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N 		increased urinary bladder carcinoma incidence J:234236
premature death J:234236
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Ptentm1Hwu/Ptentm1Hwu
Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N 		increased urinary bladder carcinoma incidence J:164579
premature death J:164579
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Sp8tm1Smb/Sp8tm1Smb
Tg(Msx2-cre)5Rem/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA 		normal limbs/digits/tail phenotype J:223057
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Upk2-cre)6Xrw/0
Tg(Upk2-HRAS*Q61L)5Xrw/0
involves: 129X1/SvJ * FVB/N 		hematuria J:234236
increased urinary bladder carcinoma incidence J:234236
premature death J:234236
Ctnnb1tm1Yy/Ctnnb1tm1.1Yy
Ptch1tm1Yy/Ptch1tm1.1Yy
Tg(Col2a1-cre)1Bhr/0
involves: 129S6/SvEvTac * C57BL/6 * SJL 		abnormal elbow joint morphology J:112462
abnormal long bone hypertrophic chondrocyte zone J:112462
abnormal perichondrium morphology J:112462
arrested osteoblast differentiation J:112462
normal craniofacial phenotype J:112462
decreased bone mineralization J:112462
delayed endochondral bone ossification J:112462
fused synovial joints J:112462
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0
involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 		abnormal eye morphology J:71744
abnormal eyelid morphology J:71744
abnormal hair follicle development J:71744
abnormal hair growth J:71744
abnormal incisor morphology J:71744
abnormal intestinal goblet cell morphology J:71744
abnormal lymph node morphology J:71744
abnormal macrophage physiology J:71744
abnormal molar morphology J:71744
abnormal Peyer's patch morphology J:71744
abnormal small intestine morphology J:71744
absent Meibomian glands J:71744
alopecia J:71744
blindness J:71744
deafness J:71744
decreased body size J:71744
decreased litter size J:71744
domed cranium J:71744
dry eyes J:71744
gastrointestinal hemorrhage J:71744
Harderian gland atrophy J:71744
hunched posture J:71744
increased granulocyte number J:71744
increased hepatocyte apoptosis J:71744
increased inflammatory response J:71744
increased leukocyte cell number J:71744
increased susceptibility to otitis media J:71744
keratoconjunctivitis sicca J:71744
kinked tail J:71744
lethargy J:71744
liver hemorrhage J:71744
prenatal lethality, incomplete penetrance J:71744
sparse hair J:71744
sparse vibrissae J:71744
tremors J:71744
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(Myh6-cre)2182Mds/0
B6.Cg-Ctnnb1tm2(Nfkbia)Rsu Tg(Myh6-cre)2182Mds 		decreased response of heart to induced stress J:111645
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1tm2(Nfkbia)Rsu
Tg(Runx2-icre)1Jtuc/0
involves: 129P2/OlaHsd * FVB/N 		normal skeleton phenotype J:160669
Ctnnb1tm2.1Kem/Ctnnb1+
Otx2tm1(Dkk1)Imat/Otx2tm1(Dkk1)Imat
involves: 129/Sv * C57BL/6 * CBA 		abnormal rostral-caudal axis patterning J:103272
Ctnnb1tm2.1Kem/Ctnnb1+
Sall4Gt(W097E01)Flo/Sall4+
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 		abnormal anterior primitive streak morphology J:138922
abnormal mesoderm development J:138922
embryonic growth retardation J:138922
preweaning lethality, complete penetrance J:138922
Ctnnb1tm2Kba/Ctnnb1tm2Kba
involves: 129S6/SvEvTac * C57BL/6 		abnormal gastrulation J:178971
absent mesoderm J:178971
embryonic lethality between implantation and somite formation, complete penetrance J:178971
Ctnnb1tm2Kem/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Cdh5-cre)7Mlia/0
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c * C57BL/6 * FVB/N 		abnormal blood vessel morphology J:135172
abnormal definitive hematopoiesis J:135172
premature death J:135172
Ctnnb1tm2Kem/Ctnnb1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Col2a1-cre)1Bhr/0
Tg(tetO-Vegfa)90Ala/0
involves: 129 * C57BL/6 * FVB/N * ICR * SJL 		increased hemangioma incidence J:156474
normal skeleton phenotype J:156474
Ctnnb1tm2Kem/Ctnnb1+
Hesx1tm1(cre)Jpmb/Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ 		abnormal forebrain development J:181005
anophthalmia J:181005
microphthalmia J:181005
small embryonic telencephalon J:181005
Ctnnb1tm2Kem/Ctnnb1+
Amer1tm1.1Nbar/Y
Tg(Prrx1-cre)1Cjt/0
involves: 129 * C57BL/6 * SJL 		normal skeleton phenotype J:173242
Ctnnb1tm2Kem/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 		abnormal osteoclast physiology J:178340
abnormal trabecular bone morphology J:178340
decreased bone trabecula number J:178340
decreased trabecular bone mass J:178340
decreased trabecular bone thickness J:178340
decreased trabecular bone volume J:178340
increased bone resorption J:178340
increased osteoclast cell number J:178340
osteoporosis J:178340
normal skeleton phenotype J:178340
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Corintm2(cre)Bamo/Corin+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129X1/SvJ * FVB/N 		abnormal auchene hair morphology J:160311
abnormal awl hair morphology J:160311
abnormal hair cycle anagen phase J:160311
abnormal hair cycle catagen phase J:160311
abnormal hair cycle telogen phase J:160311
abnormal hair follicle physiology J:160311
abnormal hair shaft morphology J:160311
abnormal zigzag hair morphology J:160311
decreased guard hair length J:160311
delayed hair regrowth J:160311
increased hair follicle apoptosis J:160311
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sor+
Tg(Zp3-cre)93Knw/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J 		abnormal embryonic tissue morphology J:187739
abnormal germ layer development J:187739
failure to gastrulate J:187739
prenatal lethality, complete penetrance J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * CBA/J 		abnormal brain morphology J:187739
abnormal craniofacial morphology J:187739
prenatal lethality, complete penetrance J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sor+
Tg(Foxn1-cre)1Tbo/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 		decreased body size J:187739
focal hair loss J:187739
normal integument phenotype J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sor+
Tg(Cdx1-cre)23Kem/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB 		caudal body truncation J:187739
prenatal lethality, complete penetrance J:187739
truncated tail bud J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sortm1(Ctnnb1)Kem
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * CBA/J 		neonatal lethality, complete penetrance J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sortm1(Ctnnb1)Kem
Tg(Cdx1-cre)23Kem/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB 		abnormal digit morphology J:187739
abnormal hindlimb morphology J:187739
abnormal neural tube morphology J:187739
abnormal rib morphology J:187739
abnormal sex gland morphology J:187739
abnormal vertebrae morphology J:187739
absent hindlimb J:187739
absent tail J:187739
brachydactyly J:187739
normal embryo phenotype J:187739
fused phalanges J:187739
open neural tube J:187739
perinatal lethality, complete penetrance J:187739
persistent cloaca J:187739
rib fusion J:187739
short ribs J:187739
small adrenal glands J:187739
small kidney J:187739
small vertebrae J:187739
vertebral fusion J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sortm1(Ctnnb1)Kem
Tg(Foxn1-cre)1Tbo/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 		decreased body size J:187739
normal integument phenotype J:187739
sparse hair J:187739
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sortm1.1(Ctnnb1)Kem
Edil3Tg(Sox2-cre)1Amc/Edil3+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA 		abnormal embryonic tissue morphology J:187739
abnormal germ layer development J:187739
failure to gastrulate J:187739
prenatal lethality, complete penetrance J:187739
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Gt(ROSA)26Sortm1(Fgf8)Lma/Gt(ROSA)26Sor+
Tg(Msx2-cre)5Rem/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA 		abnormal autopod morphology J:223057
abnormal hindlimb morphology J:223057
abnormal ulna morphology J:223057
normal limbs/digits/tail phenotype J:223057
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Gt(ROSA)26Sortm1(Fgf8)Lma/Gt(ROSA)26Sor+
Shhtm1(EGFP/cre)Cjt/Shh+
involves: 129S1/Sv * 129X1/SvJ 		abnormal reproductive system development J:223057
abnormal tail development J:223057
normal reproductive system phenotype J:223057
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129 * C57BL/6 * CBA/J 		absent hindbrain J:178971
absent mandible J:178971
absent maxilla J:178971
absent midbrain J:178971
absent midbrain-hindbrain boundary J:178971
small pharyngeal arch J:178971
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Juptm1Ruiz/Juptm1.1Tmj
Olig2tm1(cre)Tmj/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ 		abnormal dendrite morphology J:178688
lethality throughout fetal growth and development, complete penetrance J:178688
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Juptm1Ruiz/Juptm1Ruiz
Olig2tm1(cre)Tmj/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ 		abnormal neuronal migration J:178688
abnormal spinal cord lateral motor column morphology J:178688
abnormal spinal cord medial motor column morphology J:178688
abnormal spinal cord motor column morphology J:178688
abnormal ventral interneuron 1 morphology J:178688
abnormal ventral interneuron 2 morphology J:178688
decreased motor neuron number J:178688
embryonic lethality during organogenesis, complete penetrance J:178688
normal nervous system phenotype J:178688
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 		abnormal osteoclast physiology J:178340
abnormal trabecular bone morphology J:178340
decreased bone resorption J:178340
decreased osteoclast cell number J:178340
extramedullary hematopoiesis J:178340
increased bone trabecula number J:178340
increased bone volume J:178340
increased compact bone volume J:178340
increased trabecular bone thickness J:178340
increased trabecular bone volume J:178340
osteopetrosis J:178340
normal skeleton phenotype J:178340
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Tg(tetO-HIST1H2BJ/GFP)47Efu/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 		abnormal osteoclast differentiation J:178340
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ptentm1Hwu/Ptentm1Hwu
Tg(Cdh5-cre)7Mlia/0
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c * C57BL/6 * FVB/N 		embryonic lethality, complete penetrance J:135172
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Rac1tm1Djk/Rac1+
Tg(Msx2-cre)5Rem/0
involves: 129S4/SvJae 		abnormal forelimb morphology J:145305
absent hindlimb J:145305
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Tg(Tyr-cre/ERT2)13Bos/0
involves: C57BL/6J * FVB 		abnormal coat/hair pigmentation J:231435
abnormal epidermal melanocyte morphology J:231435
abnormal melanocyte differentiation J:231435
abnormal melanocyte proliferation J:231435
Ctnnb1tm2Kem/Ctnnb1tm3Kba
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129 * C57BL/6 * CBA/J 		abnormal cerebellum development J:178971
abnormal craniofacial bone morphology J:178971
absent midbrain-hindbrain boundary J:178971
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
07/05/2024
MGI 6.24 		The Jackson Laboratory